Atlas Trials

Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL

Clinical trial NCT05559450 · UNKNOWN

Trial details

NCT number
NCT05559450
Sponsor
The First Affiliated Hospital of Soochow University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
B-cell Acute Lymphoblastic Leukemia
Start date
2022-02-01
Primary completion
2024-01-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.